FMC
37
-2
IPG
49
2
PLD
43
-2
PEG
55
2
CVS
31
2
GME
54
-3
MAR
62
-3
KR
57
-6
FCX
50
-2
AVGO
88
27
ALL
41
6
WHR
70
-2
HUM
33
2
AKAM
59
-2
NEM
46
-2
EMC
71
3
LYB
25
-14
NWSA
73
-2
GOOGL
67
-2
AVB
57
-2
FMC
37
-2
IPG
49
2
PLD
43
-2
PEG
55
2
CVS
31
2
GME
54
-3
MAR
62
-3
KR
57
-6
FCX
50
-2
AVGO
88
27
ALL
41
6
WHR
70
-2
HUM
33
2
AKAM
59
-2
NEM
46
-2
EMC
71
3
LYB
25
-14
NWSA
73
-2
GOOGL
67
-2
AVB
57
-2
Financhill
Back

WuXi Biologics (Cayman) 10K Form

Buy
78

WXIBF
WuXi Biologics (Cayman)

Last Price:
2.50
Seasonality Move:
2.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive WXIBF News And Ratings

See the #1 stock for the next 7 days that we like better than WXIBF

WXIBF Financial Statistics

Sales & Book Value

Annual Sales: $2.41B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.35
Price / Book: 1.84

Profitability

EPS (TTM): 0.08340
Net Income (TTM): $365.83M
Gross Margin: $965.27M
Return on Equity: 6.19%
Return on Assets: 4.8%

WuXi Biologics (Cayman) Earnings Forecast

Key WuXi Biologics (Cayman) Financial Ratios

  • The Gross Profit Margin over the past 10 years for WXIBF is 40.08%.
  • The Selling, General & Administrative Expenses for WXIBF have been equal to 10.50% of Gross Profit Margin.
  • The Research & Development expenses have been 4.61% of Revenue.
  • The Interest Expense is 4.66% of Operating Income.
  • The Net Earning history of WXIBF is 19.96% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 8 years.

WuXi Biologics (Cayman) Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: WXIBF
Website: wuxibiologics.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 2.91
Quick Ratio: 2.4

Price-to-Earnings

Trailing P/E Ratio: 22.97
Forward P/E Ratio: 0

WXIBF Technical Analysis vs Fundamental Analysis

Buy
78
WuXi Biologics (Cayman) (WXIBF) is a Buy

Is WuXi Biologics (Cayman) a Buy or a Sell?